These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 35073459)

  • 1. LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c-Myc mRNA stability.
    Zhu Y; Zhou B; Hu X; Ying S; Zhou Q; Xu W; Feng L; Hou T; Wang X; Zhu L; Jin H
    Clin Transl Med; 2022 Jan; 12(1):e703. PubMed ID: 35073459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N6-methyladenosine reader hnRNPA2B1 recognizes and stabilizes NEAT1 to confer chemoresistance in gastric cancer.
    Wang J; Zhang J; Liu H; Meng L; Gao X; Zhao Y; Wang C; Gao X; Fan A; Cao T; Fan D; Zhao X; Lu Y
    Cancer Commun (Lond); 2024 Apr; 44(4):469-490. PubMed ID: 38512764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PCAT-1 contributes to cisplatin resistance in gastric cancer through miR-128/ZEB1 axis.
    Guo Y; Yue P; Wang Y; Chen G; Li Y
    Biomed Pharmacother; 2019 Oct; 118():109255. PubMed ID: 31352238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA SNHG6 knockdown inhibits cisplatin resistance and progression of gastric cancer through miR-1297/BCL-2 axis.
    Mei J; Liu G; Li R; Xiao P; Yang D; Bai H; Hao Y
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34821362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNautophagic regulation of DNMT3a-dependent DNA methylation by Linc00942 enhances chemoresistance in gastric cancer.
    Zhu L; Zhu Y; Li F; Meng Y; Wang H; Xu W; Luo J; Wang X; Feng L; Jin H
    Clin Transl Med; 2023 Jul; 13(7):e1337. PubMed ID: 37477089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LNC942 promoting METTL14-mediated m
    Sun T; Wu Z; Wang X; Wang Y; Hu X; Qin W; Lu S; Xu D; Wu Y; Chen Q; Ding X; Guo H; Li Y; Wang Y; Fu B; Yao W; Wei M; Wu H
    Oncogene; 2020 Jul; 39(31):5358-5372. PubMed ID: 32576970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia inducible lncRNA-CBSLR modulates ferroptosis through m6A-YTHDF2-dependent modulation of CBS in gastric cancer.
    Yang H; Hu Y; Weng M; Liu X; Wan P; Hu Y; Ma M; Zhang Y; Xia H; Lv K
    J Adv Res; 2022 Mar; 37():91-106. PubMed ID: 35499052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HOXD-AS1 confers cisplatin resistance in gastric cancer through epigenetically silencing PDCD4 via recruiting EZH2.
    Ye Y; Yang S; Han Y; Sun J; Xv L; Wu L; Ming L
    Open Biol; 2019 Sep; 9(9):190068. PubMed ID: 31551012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propofol facilitates cisplatin sensitivity via lncRNA MALAT1/miR-30e/ATG5 axis through suppressing autophagy in gastric cancer.
    Zhang YF; Li CS; Zhou Y; Lu XH
    Life Sci; 2020 Mar; 244():117280. PubMed ID: 31926239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma.
    Tao X; Li Y; Fan S; Wu L; Xin J; Su Y; Xian X; Huang Y; Huang R; Fang W; Liu Z
    J Exp Clin Cancer Res; 2023 Jan; 42(1):12. PubMed ID: 36627670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HOXC-AS1-MYC regulatory loop contributes to the growth and metastasis in gastric cancer.
    Dong Y; Li X; Lin Z; Zou W; Liu Y; Qian H; Jia J
    J Exp Clin Cancer Res; 2019 Dec; 38(1):502. PubMed ID: 31870402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a competing endogenous RNA network and identification of potential regulatory axes in gastric cancer chemoresistance.
    Yang XZ; Ma L; Fang SX; Song Y; Zhu SY; Jin C; Liu W; Lu Q; Zeng LS; Cui SZ
    Pathol Res Pract; 2022 Jun; 234():153904. PubMed ID: 35487029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c-Myc mRNA stability.
    Yang F; Xue X; Zheng L; Bi J; Zhou Y; Zhi K; Gu Y; Fang G
    FEBS J; 2014 Feb; 281(3):802-13. PubMed ID: 24397586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCP5 contributes to cisplatin resistance in gastric cancer through miR-128/HMGA2 axis.
    Liang L; Kang H; Jia J
    Cell Cycle; 2021 Jun; 20(11):1080-1090. PubMed ID: 33993846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LCAT3, a novel m6A-regulated long non-coding RNA, plays an oncogenic role in lung cancer via binding with FUBP1 to activate c-MYC.
    Qian X; Yang J; Qiu Q; Li X; Jiang C; Li J; Dong L; Ying K; Lu B; Chen E; Liu P; Lu Y
    J Hematol Oncol; 2021 Jul; 14(1):112. PubMed ID: 34274028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LOC101929709 promotes gastric cancer progression by aiding LIN28B to stabilize c-MYC mRNA.
    Xu TP; Yu T; Xie MY; Fang Y; Xu TT; Pan YT; Ma P; Shu YQ
    Gastric Cancer; 2023 Mar; 26(2):169-186. PubMed ID: 36284068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA SNHG8 promotes chemoresistance in gastric cancer via binding with hnRNPA1 and stabilizing TROY expression.
    Zhu W; Tan L; Ma T; Yin Z; Gao J
    Dig Liver Dis; 2022 Nov; 54(11):1573-1582. PubMed ID: 35354542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low SP1 SUMOylation-dependent SNHG17 upregulation promotes drug resistance of gastric cancer through impairing hsa-miR-23b-3p-induced Notch2 inhibition.
    Huang G; Cai G; Hu D; Li J; Xu Q; Chen Z; Xu B
    Cell Oncol (Dordr); 2022 Dec; 45(6):1329-1346. PubMed ID: 36214997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. m
    Yang D; Chang S; Li F; Ma M; Yang J; Lv X; Huangfu L; Jia C
    IUBMB Life; 2021 Nov; 73(11):1325-1333. PubMed ID: 34409730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An oncogenic lncRNA, GLCC1, promotes tumorigenesis in gastric carcinoma by enhancing the c-Myc/IGF2BP1 interaction.
    Yang DL; Dong LF; Qiu YB; Luo GY
    Neoplasma; 2021 Sep; 68(5):1052-1062. PubMed ID: 34196212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.